Flinn, I. W., Kahl, B. S., Leonard, J. P., Furman, R. R., Brown, J. R., Byrd, J. C., . . . Spurgeon, S. E. (2014). Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma. Blood.
Dyfyniad Arddull ChicagoFlinn, Ian W., et al. "Idelalisib, a Selective Inhibitor of Phosphatidylinositol 3-kinase-δ, As Therapy for Previously Treated Indolent Non-Hodgkin Lymphoma." Blood 2014.
Dyfyniad MLAFlinn, Ian W., et al. "Idelalisib, a Selective Inhibitor of Phosphatidylinositol 3-kinase-δ, As Therapy for Previously Treated Indolent Non-Hodgkin Lymphoma." Blood 2014.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.